GALECTIN THERAPEUTICS INC
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
GALT$3.38-2.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Item 8. | Financial Statements and Supplementary Data |
|---|
The financial statements required by this item are attached to this Annual Report on Form 10-K beginning on Page F-1.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.